Computer-Aided Evaluation of Breast MRI for the Residual Tumor Extent and Response Monitoring in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
![]() ![]() |
Lyou, Chae-Yeon
(Department of Radiology and Clinical Research Institute, Seoul National University Hospital and the Institute of Radiation Medicine, Seoul National University Medical Research Center)
Cho, Nariya (Department of Radiology and Clinical Research Institute, Seoul National University Hospital and the Institute of Radiation Medicine, Seoul National University Medical Research Center) Kim, Sun-Mi (Department of Radiology, Seoul National University Bundang Hospital) Jang, Mi-Jung (Department of Radiology, Seoul National University Bundang Hospital) Park, Jeong-Seon (Department of Radiology, Hanyang University College of Medicine, Hanyang University Hospital) Baek, Seung-Yon (Department of Radiology, School of Medicine, Ewha Womans University) Moon, Woo-Kyung (Department of Radiology and Clinical Research Institute, Seoul National University Hospital and the Institute of Radiation Medicine, Seoul National University Medical Research Center) |
1 | Esteva FJ, Hortobagyi GN. Locally advanced breast cancer. Hematol Oncol Clin North Am 1999;13:457-472 DOI |
2 | Kaufmann M, von Minckwitz G, Smith R, Valero V, Gianni L, Eiermann W, et al. International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. J Clin Oncol 2003;21:2600-2608 DOI ScienceOn |
3 | Estevez LG, Gradishar WJ. Evidence-based use of neoadjuvant taxane in operable and inoperable breast cancer. Clin Cancer Res 2004;10:3249-3261 DOI ScienceOn |
4 | Shimizu C, Ando M, Kouno T, Katsumata N, Fujiwara Y. Current trends and controversies over pre-operative chemotherapy for women with operable breast cancer. Jpn J Clin Oncol 2007;37:1-8 DOI |
5 | Buchholz TA, Lehman CD, Harris JR, Pockaj BA, Khouri N, Hylton NF, et al. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. J Clin Oncol 2008;26:791-797 DOI ScienceOn |
6 | Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998;16:2672-2685 DOI |
7 | Kuerer HM, Newman LA, Smith TL, Ames FC, Hunt KK, Dhingra K, et al. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 1999;17:460-469 DOI |
8 | Bonadonna G, Valagussa P, Brambilla C, Ferrari L, Moliterni A, Terenziani M, et al. Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute. J Clin Oncol 1998;16:93-100 DOI |
9 | Buchholz TA, Hill BS, Tucker SL, Frye DK, Kuerer HM, Buzdar AU, et al. Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy. Cancer J 2001;7:413-420 |
10 | Lee SH, Cho N, Kim SJ, Cha JH, Cho KS, Ko ES, et al. Correlation between high resolution dynamic MR features and prognostic factors in breast cancer. Korean J Radiol 2008;9:10-18 DOI ScienceOn |
11 | Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-216 DOI ScienceOn |
12 | Therasse P, Eisenhauer EA, Verweij J. RECIST revisited: a review of validation studies on tumour assessment. Eur J Cancer 2006;42:1031-1039 DOI ScienceOn |
13 | Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228-247 DOI ScienceOn |
14 | Balu-Maestro C, Chapellier C, Bleuse A, Chanalet I, Chauvel C, Largillier R. Imaging in evaluation of response to neoadjuvant breast cancer treatment benefi ts of MRI. Breast Cancer Res Treat 2002;72:145-152 DOI ScienceOn |
15 | Abraham DC, Jones RC, Jones SE, Cheek JH, Peters GN, Knox SM, et al. Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer 1996;78:91-100 DOI ScienceOn |
16 | Drew PJ, Kerin MJ, Mahapatra T, Malone C, Monson JR, Turnbull LW, et al. Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast. Eur J Surg Oncol 2001;27:617-620 DOI ScienceOn |
17 | Gilles R, Guinebretiere JM, Toussaint C, Spielman M, Rietjens M, Petit JY, et al. Locally advanced breast cancer: contrastenhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 1994;191:633-638 DOI |
18 | Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Sudilovsky D, Hylton NM. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 2002;179:1193-1999 DOI ScienceOn |
19 | Weatherall PT, Evans GF, Metzger GJ, Saborrian MH, Leitch AM. MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation. J Magn Reson Imaging 2001;13:868-875 DOI ScienceOn |
20 | Rosen EL, Blackwell KL, Baker JA, Soo MS, Bentley RC, Yu D, et al. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol 2003;181:1275-1282 DOI ScienceOn |
21 | Rieber A, Zeitler H, Rosenthal H, Gorich J, Kreienberg R, Brambs HJ, et al. MRI of breast cancer: influence of chemotherapy on sensitivity. Br J Radiol 1997;70:452-458 DOI |
22 | Wasser K, Sinn HP, Fink C, Klein SK, Junkermann H, Lüdemann HP, et al. Accuracy of tumor size measurement in breast cancer using MRI is infl uenced by histological regression induced by neoadjuvant chemotherapy. Eur Radiol 2003;13:1213-1223 |
23 | Demartini WB, Lehman CD, Peacock S, Russell MT. Computeraided detection applied to breast MRI: assessment of CAD-generated enhancement and tumor sizes in breast cancers before and after neoadjuvant chemotherapy. Acad Radiol 2005;12:806-814 DOI ScienceOn |
24 | Wang LC, DeMartini WB, Partridge SC, Peacock S, Lehman CD. MRI-detected suspicious breast lesions: predictive values of kinetic features measured by computer-aided evaluation. AJR Am J Roentgenol 2009;193:826-831 DOI ScienceOn |
25 | Lehman CD, Peacock S, DeMartini WB, Chen X. A new automated software system to evaluate breast MR examinations: improved specifi city without decreased sensitivity. AJR Am J Roentgenol 2006;187:51-56 DOI ScienceOn |
26 | American College of Radiology. BIRADS: ultrasound. In: Breast imaging reporting and data system: BIRADS atlas. 4th ed. Reston, VA: American College of Radiology, 2003 |
27 | Suzuki C, Jacobsson H, Hatschek T, Torkzad MR, Boden K, Eriksson-Alm Y, et al. Radiologic measurements of tumor response to treatment: practical approaches and limitations. Radiographics 2008;28:329-344 DOI ScienceOn |
28 | Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310 |
29 | Rieber A, Brambs HJ, Gabelmann A, Heilmann V, Kreienberg R, Ku¨hn T. Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol 2002;12:1711-1719 DOI ScienceOn |
30 | Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Tripathy D, Wolverton DS, et al. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol 2005;184:1774-1781 DOI ScienceOn |
31 | Hylton N, Blurne J, Bernreuter W, Pisano E, Rosen M, Morris E. MRI assessment of breast cancer response to neoadjuvant chemotherapy: Preliminary findings of the American College of Radiology Imaging Network (ACRIN) Trial 6657 [abstr]. In: Radiological Society of North America scientific assembly and annual meeting program. Available via http://rsna2008.rsna.org/event_display.cfm?em_id=6006524, unpublished data |
![]() |